Guru Ownership Trend
Guru Analysis for BioMarin Pharmaceutical Inc. (BMRN)
BioMarin Pharmaceutical Inc. (BMRN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 13 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $873.03 M.
Top institutional holders include Cliff Asness and Andreas Halvorsen.
Institutional sentiment is currently Bearish. This is evidenced by a $53.15 M net outflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Ray Dalio reduced exposure by 38.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for BioMarin Pharmaceutical Inc. (BMRN)
Major holders include Cliff Asness ($395.2 M), Andreas Halvorsen ($358.78 M), Renaissance Technologies (RenTech) ($78.74 M). According to the latest reported data, 13 tracked investment managers collectively hold approximately 15.97 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $53.15 M, with 8 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited BMRN. The total reported sell value was $178.26 M.
Yes, 4 managers opened new positions in BMRN, and 4 increased their existing holdings. The total reported buy value was $125.11 M.
